Clinical Trials Directory

Trials / Completed

CompletedNCT00555490

Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With Nephropathy

Soy-Protein Intake, Cardio-Renal Indices and C-Reactive Protein in Type 2 Diabetes With Nephropathy: a 4-y Randomized Clincal Trial

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

we conducted a longitudinal 4-year clinical trial to determine the long-term effects of soy consumption on lipid profiles, renal-function indices and CRP level among type 2 diabetic patients with nephropathy.

Detailed description

Background: Several short-term trials on the effect of soy consumption on cardiovascular risks are available, but little evidence exists regarding the impact of long-term soy protein consumption among type 2 diabetic patients with nephropathy. Objectives: To determine the effects of long-term soy consumption on cardiovascular risks, C-reactive protein and kidney-function indices among type 2 diabetic patients with nephropathy. Design: This longitudinal randomized clinical trial was conducted among 41 type 2 diabetic patients with nephropathy (18 men and 23 women). Twenty patients in soy protein group consumed a diet containing 0.8 g protein/kg body weight (35% animal proteins, 35% textured soy protein, and 30% vegetable proteins) and 21 patients in control group consumed a similar diet containing 70% animal proteins and 30% vegetable proteins for 4-years.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSoy protein35 % of protein from soy protein for 4-years

Timeline

Start date
2001-04-01
Completion
2005-09-01
First posted
2007-11-08
Last updated
2007-11-08

Source: ClinicalTrials.gov record NCT00555490. Inclusion in this directory is not an endorsement.